Abstract
• Accurate estimation of baseline cardiovascular (CV) risk and relative risk reduction (RRR) is crucial to ensure that economic evaluations of new health technologies for the treatment of type 2 diabetes (T2DM) are robust. • Many economic models (such as the IMS CORE Diabetes Model [1]) use risk equations (RE) derived from UKPDS and concerns persist regarding their validity; particularly as new equations are published. • The potential choice of risk equations is large; a recent review [2] identified twelve cardiovascular disease risk equations derived from cohorts with T2DM. • The objective of this study was to compare the consistency of predicted CV risk using RE derived from various T2DM populations. Objectives
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
